These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 25628512)

  • 1. Transthyretin cardiac amyloidosis: pathogenesis, treatments, and emerging role in heart failure with preserved ejection fraction.
    Ton VK; Mukherjee M; Judge DP
    Clin Med Insights Cardiol; 2014; 8(Suppl 1):39-44. PubMed ID: 25628512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of transthyretin amyloidosis in patients with heart failure and no left ventricular hypertrophy.
    Devesa A; Camblor Blasco A; Pello Lázaro AM; Askari E; Lapeña G; Gómez Talavera S; Taibo Urquía M; Rodríguez Olleros C; Tuñón J; Ibáñez B; Aceña Á
    ESC Heart Fail; 2021 Aug; 8(4):2856-2865. PubMed ID: 33963812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction.
    González-López E; Gallego-Delgado M; Guzzo-Merello G; de Haro-Del Moral FJ; Cobo-Marcos M; Robles C; Bornstein B; Salas C; Lara-Pezzi E; Alonso-Pulpon L; Garcia-Pavia P
    Eur Heart J; 2015 Oct; 36(38):2585-94. PubMed ID: 26224076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transthyretin amyloid fibrils alter primary fibroblast structure, function, and inflammatory gene expression.
    Dittloff KT; Iezzi A; Zhong JX; Mohindra P; Desai TA; Russell B
    Am J Physiol Heart Circ Physiol; 2021 Jul; 321(1):H149-H160. PubMed ID: 34018852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Phenotyping of Transthyretin Cardiac Amyloidosis with Bone-Seeking Radiotracers in Heart Failure with Preserved Ejection Fraction.
    Chen W; Ton VK; Dilsizian V
    Curr Cardiol Rep; 2018 Mar; 20(4):23. PubMed ID: 29520480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive Diagnostic Modalities in an Isolated Case of Cardiac Amyloidosis.
    Lewars J; Wazir H; Gordon B; Faluyi U; Girgis Y
    Cureus; 2021 Apr; 13(4):e14608. PubMed ID: 34040908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac amyloidosis: An underdiagnosed/underappreciated disease.
    Manolis AS; Manolis AA; Manolis TA; Melita H
    Eur J Intern Med; 2019 Sep; 67():1-13. PubMed ID: 31375251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Most Predictive Red Flags for Suspecting Cardiac Amyloidosis in Patients with Heart Failure with Preserved Ejection Fraction.
    Yalvaç HE; Murat S; Ak Sivrikoz İ; Üsküdar Teke H; Çilingir O; Çolak E; Çavuşoğlu Y
    Turk Kardiyol Dern Ars; 2024 Jun; 52(4):227-236. PubMed ID: 38829635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in the treatment of transthyretin cardiac amyloidosis: Current and emerging therapies.
    Warner AL
    Pharmacotherapy; 2021 Dec; 41(12):1081-1091. PubMed ID: 34669976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolated heart transplantation for familial transthyretin (TTR) V122I cardiac amyloidosis.
    Thenappan T; Fedson S; Rich J; Murks C; Husain A; Pogoriler J; Anderson AS
    Amyloid; 2014 Jun; 21(2):120-3. PubMed ID: 24818650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments.
    Sekijima Y
    J Neurol Neurosurg Psychiatry; 2015 Sep; 86(9):1036-43. PubMed ID: 25604431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the Amyloidogenesis of Transthyretin by Natural Products and Synthetic Compounds.
    Yokoyama T; Mizuguchi M
    Biol Pharm Bull; 2018; 41(7):979-984. PubMed ID: 29962408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid fibril composition and transthyretin gene structure in senile systemic amyloidosis.
    Gustavsson A; Jahr H; Tobiassen R; Jacobson DR; Sletten K; Westermark P
    Lab Invest; 1995 Nov; 73(5):703-8. PubMed ID: 7474944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Light-Chain (AL) Cardiac Amyloidosis Presenting as Heart Failure With Reduced Ejection Fraction.
    Santiago LE; Alvi AT; Melnychuk V; Mesquita P; Aneja P
    Cureus; 2024 Feb; 16(2):e55271. PubMed ID: 38558722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory and Molecular Pathways in Heart Failure-Ischemia, HFpEF and Transthyretin Cardiac Amyloidosis.
    Michels da Silva D; Langer H; Graf T
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31083399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transthyretin deposition alters cardiomyocyte sarcomeric architecture, calcium transients, and contractile force.
    Dittloff KT; Spanghero E; Solís C; Banach K; Russell B
    Physiol Rep; 2022 Mar; 10(5):e15207. PubMed ID: 35262277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasminogen activation triggers transthyretin amyloidogenesis
    Mangione PP; Verona G; Corazza A; Marcoux J; Canetti D; Giorgetti S; Raimondi S; Stoppini M; Esposito M; Relini A; Canale C; Valli M; Marchese L; Faravelli G; Obici L; Hawkins PN; Taylor GW; Gillmore JD; Pepys MB; Bellotti V
    J Biol Chem; 2018 Sep; 293(37):14192-14199. PubMed ID: 30018138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transthyretin-related amyloidotic cardiomyopathy: looking for the etiological treatment].
    Longhi S; Gagliardi C; Milandri A; Manuzzi L; Rapezzi C
    G Ital Cardiol (Rome); 2014 May; 15(5):293-300. PubMed ID: 25002169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wild type transthyretin cardiac amiloidozis as a rare and overlooked underlying etiology in a patient with heart failure with preserved ejection fraction and left ventricular hypertrophy.
    Murat S; Çavuşoğlu Y; Ak Sivrikoz İ
    Turk Kardiyol Dern Ars; 2021 Oct; 49(7):579-584. PubMed ID: 34623301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genistein, a natural product from soy, is a potent inhibitor of transthyretin amyloidosis.
    Green NS; Foss TR; Kelly JW
    Proc Natl Acad Sci U S A; 2005 Oct; 102(41):14545-50. PubMed ID: 16195386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.